Thirty-day mortality following systemic anticancer therapy: evaluating risk factors without selection bias in a real-world, population-based cohort from 2009 to

HIGHLIGHTS

• who: C. Vesteghem from the Link to from University of Clinical Medicine, University, Denmark have published the research work: Thirty-Day Mortality Following Systemic Anticancer Therapy: Evaluating Risk Factors Without Selection Bias in a Real-World, Population-Based Cohort From 2009 to, in the Journal: (JOURNAL)
• what: The authors report a significant downward trend for the 30-day mortality following SACT using both indicators for palliative SACTs over an 11-year period. In line with recent studies , the authors report a decrease in 30-day mortality over time, notably for palliative SACTs.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.